Mark Keim
Mr. Keim will continue as the Company’s chief financial officer with expanded operational and growth-related responsibilities
Highest-materiality recent filing
Molina wins Illinois Medicaid contract; go-live Jan 2027, 4.5-year term
Illinois HFS intends to award HealthChoice Illinois Medicaid contract to Molina's Illinois subsidiary.
Molina shareholders approve 1.5M share increase to equity plan and 20% special meeting right
Approved amendment to 2025 Equity Incentive Plan increasing authorized shares from 1,795,000 to 3,295,000 (1.5M new shares).
Molina Healthcare holds 2026 Investor Day; no specific financial targets disclosed in filing
Company hosted Investor Day on May 8, 2026, discussing long-term financial targets and strategic plans.
Molina Q1 GAAP EPS $0.27 vs $5.45 YoY; revenue $10.8B down 3.1%
Adjusted EPS of $2.35 vs $6.08 in prior-year quarter; net income $14M vs $298M.
Full-year 2026 GAAP diluted EPS guidance reaffirmed at at least $3.20.
Molina Healthcare records $93M impairment, eases credit covenant through amendment
Pre-tax non-cash impairment charge of ~$93M in Q1 2026 from exiting Medicare Advantage Prescription Drug product for 2027.
Molina Healthcare reports Q4 GAAP loss of $3.15 per share; full-year 2025 EPS down 56%
Q4 2025 GAAP net loss of $160M vs. net income of $251M in Q4 2024; adjusted loss per share $2.75.
Molina Healthcare closes $850M offering of 6.5% Senior Notes due 2031
Closed private offering of $850M aggregate principal of 6.5% Senior Notes due Feb 15, 2031; net proceeds ~$838M.
Molina Healthcare prices $850M of 6.500% senior notes due 2031
Issued $850M aggregate principal of 6.500% senior notes maturing Feb 15, 2031.
Intends to privately offer $750M senior notes due 2031 to repay existing delayed draw term loans and replace credit facility.
Molina awarded sole Florida Medicaid contract; $5B in annual premiums expected
Florida AHCA selected Molina as sole plan for SMMC and CHIP services for ~120,000 enrollees.
Molina Healthcare Q3 GAAP EPS $1.51 vs $5.65 YoY; full-year guidance revised
Q3 2025 GAAP net income $79M ($1.51 diluted EPS) vs $326M ($5.65) a year ago; adjusted EPS $1.84 vs $6.01.
Molina Healthcare adds $500M delayed draw term loan to fund share repurchases
Added $500M Delayed Draw A-2 Term Loan facility under amended Credit Agreement maturing August 12, 2027.
Molina Q2 GAAP EPS $4.75, down 8% YoY; net income falls to $255M
GAAP net income $255M ($4.75 diluted) vs $301M ($5.17) in Q2 2024; adjusted net income $294M ($5.48) vs $341M ($5.86).
Molina Healthcare cuts FY25 adjusted EPS guidance to $21.50-$22.50; Q2 preliminary $5.50
Q2 2025 preliminary adjusted EPS ~$5.50, modestly below prior expectations due to medical cost pressures across all lines of business.
Molina shareholders reject say-on-pay, approve 2025 equity plan and special meeting proposal
Say-on-pay failed: 26,653,672 votes against vs 18,249,700 for, with 1,848,771 broker non-votes.
Molina Healthcare Q1 GAAP EPS $5.45, Adjusted $6.08; Reaffirms FY2025 Guidance
Total revenue $11.147B, up 12% YoY from $9.931B; premium revenue $10.628B.
Molina wins Illinois D-SNP contract; serves ~73k beneficiaries starting Jan 2026
Molina subsidiary one of four MCOs awarded Illinois D-SNP contract by Dept. of Healthcare & Family Services.
Molina Healthcare adds $500M delayed draw term loan facility via credit agreement amendment
Delayed Draw Term Loan facility of $500M established under amended credit agreement dated Feb 19, 2025.
Molina Q4 GAAP EPS $4.44, adjusted $5.05; full-year adjusted EPS $22.65; introduces 2025 guidance
Q4 premium revenue $9,983M (+19% YoY); total revenue $10,499M.
Molina Healthcare closes acquisition of ConnectiCare, adding ~140,000 members
Acquisition of ConnectiCare Holding Company closed effective Feb 1, 2025.
Molina awarded HIDE SNP contract in Michigan; Idaho intends to award MMCP/IMPlus contracts
Michigan MDHHS awarded Molina Healthcare of Michigan a HIDE SNP contract for 11 regions in lower peninsula; go-live Jan 1, 2026.
Molina Healthcare closes $750M 6.250% senior notes due 2033
Issued $750M aggregate principal amount of 6.250% Senior Notes due Jan 15, 2033.
Molina Healthcare announces proposed $500M offering of senior notes due 2033
Senior notes due 2033 in $500M aggregate principal; private placement under Rule 144A/Reg S.
Molina Healthcare prices $750M of 6.250% senior notes due 2033
Principal amount $750M; coupon 6.250% paid semi-annually; maturity Jan 15, 2033.
Michigan cancels Molina's notice of intent to award Medicare dual-eligible contract; re-issues RFP
Michigan procurement office cancelled the notice of intent to award Molina contracts for the Highly Integrated Dual Eligible Special Needs Medicare population.
Molina Healthcare holds Investor Day, reaffirms full-year 2024 guidance
Investor Day held Nov 8, 2024; discussion of long-term financial targets and strategic plans.
Molina Q3 GAAP EPS $5.65, adjusted $6.01; reaffirms FY guidance
Q3 premium revenue $9.694B, up 17.6% YoY from $8.24B.
Molina grants CFO Mark Keim 53,074 performance-based RSUs tied to 2027 EPS goals
CFO Mark Keim receives 53,074 target PSUs (max 79,611) under 2019 Equity Incentive Plan.
Molina awarded Michigan contract for dual-eligible plan MI Coordinated Health; go-live Jan 2026
Michigan DHHS awarded Molina Healthcare of Michigan a HIDE SNP contract for six service regions.
Molina Healthcare increases revolver to $1.25B, extends maturity to 2029
Revolving credit facility increased from $1.0B to $1.25B.
Molina Healthcare grants CEO Zubretsky 146,184 performance-based RSUs to retain him through 2027
CEO Joseph M. Zubretsky received a special one-time PSU award of 146,184 target shares (max 219,276) under the 2019 Equity Incentive Plan.
Molina Healthcare Q2 2024 adj EPS $5.86 beats prior year $5.65; reaffirms FY guide
GAAP EPS $5.17 (vs $5.35 YoY); adjusted EPS $5.86 (vs $5.65 YoY).
Molina Healthcare stockholders elect all nine directors, approve say-on-pay, ratify Ernst & Young
All nine director nominees elected with at least 41.9M votes each; closest race was Ronna Romney with 41.99M for.
Molina Q1 GAAP EPS $5.17, adjusted $5.73; revenue rises to $9.93B; reaffirms FY2024 guidance
Q1 GAAP EPS $5.17 vs $5.52 YoY; adjusted EPS $5.73 vs $5.81.
Molina Healthcare wins Michigan Medicaid contract in six service regions; go-live Oct 1, 2024
Michigan DHHS intends to award a Comprehensive Health Care Program contract to Molina Healthcare of Michigan.
Molina not selected for Virginia's Cardinal Care contract; current deal continues into summer 2024
Molina Healthcare of Virginia was not chosen as an awardee in the Commonwealth's Cardinal Care Managed Care program.
Molina Healthcare Q4 GAAP EPS $3.70, adjusted $4.38; FY2023 GAAP EPS $18.77
Q4 premium revenue $8.36B (+5.6% YoY), total revenue $9.05B; MCR 89.1%, G&A 7.1%.
Molina Healthcare closes Bright Healthcare California Medicare buy; adds 109K members
Acquisition of Bright Healthcare's California Medicare business closed effective January 1, 2024.
Molina Healthcare adopts amended bylaws with universal proxy rules and exclusive forum
Amended bylaws require compliance with SEC Rule 14a-19 universal proxy for director nominations.
Molina Healthcare amends Bright HealthCare deal; purchase price cut to ~$425M from $510M
Purchase price reduced to ~$425M (net of tax benefits) from previously announced $510M.
Molina Healthcare Q3 GAAP EPS $4.21, adjusted $5.05; revenue up 7.8% YoY
GAAP EPS $4.21 (Q3 2022: $3.95); adjusted EPS $5.05 (Q3 2022: $4.36).
Indiana not offering Molina long-term care contract for Pathways for Aging program
Indiana FSSA notified Molina on Sept 27, 2023 it will not offer a long-term services contract for Pathways for Aging effective July 1, 2024.
Molina Healthcare closes acquisition of My Choice Wisconsin on Sep 1, 2023
Acquisition of My Choice Wisconsin closed on September 1, 2023.
Molina Healthcare of New Mexico awarded Medicaid contract; go-live July 2024
New Mexico HSD intends to award Molina a Medicaid managed care contract under the Turquoise Care program.
Molina Healthcare board adopts annual Say-on-Pay vote after 94.9% shareholder support
Filed 8-K/A to disclose board decision on advisory vote frequency.
Molina Healthcare Q2 GAAP EPS $5.35, adj. $5.65; raises full-year guidance
GAAP EPS $5.35, adjusted EPS $5.65; net income $309M, up 24.6% YoY ($248M).
Molina Healthcare to acquire Bright HealthCare's California Medicare business for $510M
Purchase price ~$510M, net of tax benefits; represents 28% of expected 2023 premium revenue of $1.8B.
Molina Healthcare promotes Jim Woys to COO, Mark Keim remains CFO with expanded role
Jim Woys promoted to senior executive VP and COO, effective May 15, 2023.
Molina Healthcare stockholders elect all nine director nominees at annual meeting
93.51% of outstanding shares voted (54,488,955 of 58,268,825) as of March 8, 2023 record date.
Mr. Keim will continue as the Company’s chief financial officer with expanded operational and growth-related responsibilities
Mr. Woys assumed the role of the Company’s chief operating officer
Max materiality 0.85 · Median 0.65 · Most common event other_material